Clinical Trial Update: Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. [Phase 4]

View source ↗

Summary

This Phase 4 trial update evaluates immunogenicity, antibody persistence, and safety of GSK's DTPa INFANRIX and dTpa BOOSTRIX vaccines; the study status is term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)
• Infanrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acellular Pertussis, Tetanus | Phase 4 | Status: TERMINATED